As part of the live broadcast series by AtlanticLive titled “The Next Drugs: An Atlantic Policy Update on Biosimilar”, Foley partner Courtenay Brinckerhoff will join the panel of speakers to address the current Supreme Court case on the patent dance, intellectual property and exclusivity issues, and the way forward.
The speakers include:
- Courtenay Brinckerhoff, Partner, Foley & Lardner LLP
- Phil Nickson, Associate General Counsel for IP, Momenta Pharmaceuticals
- Representative Peter Welch (D-VT)
- Steve Clemons, Washington Editor at Large, The Atlantic
- Olga Khazan, Staff Writer, The Atlantic
For more information and to register, please visit AtlanticLive’s website.
People
Related Insights
June 3, 2025
Foley Corporate Governance Update
Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders
On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
September 25, 2025
Events
Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.